Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Income taxes - deferred | 489,000 | N/A | N/A | N/A | N/A |
| Other Working Capital | -438,000 | -1,397,000 | -62,000 | -17,000 | -295,000 |
| Other Operating Activity | 961,000 | 3,543,000 | 1,890,000 | 1,306,000 | 1,282,000 |
| Operating Cash Flow | $1,012,000 | $2,146,000 | $1,828,000 | $1,289,000 | $987,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -158,000 | -313,000 | -174,000 | -178,000 | -158,000 |
| Net Acquisitions | -38,000 | -1,055,000 | 0 | 1,031,000 | -240,000 |
| Purchase Of Investment | -25,000 | -37,000 | -39,000 | -19,000 | -16,000 |
| Sale Of Investment | N/A | 1,038,000 | 16,000 | -1,020,000 | 1,098,000 |
| Purchase Sale Intangibles | 303,000 | -136,000 | -66,000 | -92,000 | 126,000 |
| Other Investing Activity | 438,000 | 39,000 | 34,000 | 41,000 | 245,000 |
| Investing Cash Flow | $130,000 | $-464,000 | $-229,000 | $-254,000 | $835,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -10,000 | 6,000 | 6,000 | 27,000 | -2,000 |
| Common Stock Issued | 118,000 | 150,000 | 55,000 | 82,000 | 8,000 |
| Common Stock Repurchased | -257,000 | -366,000 | -986,000 | -544,000 | -331,000 |
| Dividend Paid | -847,000 | -809,000 | -814,000 | -967,000 | -816,000 |
| Other Financing Activity | -236,000 | -273,000 | -116,000 | -372,000 | -170,000 |
| Financing Cash Flow | $-1,232,000 | $-1,292,000 | $-1,855,000 | $-1,774,000 | $-1,311,000 |
| Exchange Rate Effect | -26,000 | -47,000 | -27,000 | 5,000 | -39,000 |
| Beginning Cash Position | 5,606,000 | 5,262,000 | 5,545,000 | 6,279,000 | 5,807,000 |
| End Cash Position | 5,490,000 | 5,605,000 | 5,262,000 | 5,545,000 | 6,279,000 |
| Net Cash Flow | $-90,000 | $390,000 | $-256,000 | $-739,000 | $511,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,012,000 | 2,146,000 | 1,828,000 | 1,289,000 | 987,000 |
| Capital Expenditure | -255,000 | -465,000 | -287,000 | -307,000 | -269,000 |
| Free Cash Flow | 757,000 | 1,681,000 | 1,541,000 | 982,000 | 718,000 |